Gw&K Investment Management, LLC Alkermes Plc. Transaction History

Gw&K Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$27.94 - $44.61 $9.09 Million - $14.5 Million	-325,266 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$38.6 - $46.12 $61,335 - $73,284	-1,589 Reduced 0.49%	325,266 $13.8 Million
Q2 2018 Aug 07, 2018	SELL	$40.56 - $51.36 $258,123 - $326,855	-6,364 Reduced 1.91%	326,855 $13.5 Million
Q1 2018 May 08, 2018	BUY	$53.61 - $67.26 $1.42 Million - $1.79 Million	26,541 Added 8.65%	333,219 $19.3 Million
Q4 2017 Jan 19, 2018	SELL	$47.69 - $55.39 $88,369 - $102,637	-1,853 Reduced 0.6%	306,678 $16.8 Million
Q3 2017 Oct 11, 2017	BUY	$49.16 - $54.45 $15.2 Million - $16.8 Million	308,531	308,531 $15.7 Million

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gw&K Investment Management, LLC with notifications on news.